Bupivacaine Hydrochloride Patent Expiration
Bupivacaine Hydrochloride is Used for providing post-surgical analgesia through local anesthesia for up to 24 hours following implantation. It was first introduced by Hospira Inc
Bupivacaine Hydrochloride Patents
Given below is the list of patents protecting Bupivacaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Xaracoll | US11746141 | Modified collagen | Jan 09, 2033 | Innocoll Pharms |
| Xaracoll | USRE47826 | Drug delivery device for providing local analgesia, local anesthesia or nerve blockage | May 20, 2029 | Innocoll Pharms |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Bupivacaine Hydrochloride's patents.
Latest Legal Activities on Bupivacaine Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Bupivacaine Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical | 05 Sep, 2023 | US11746141 |
| Recordation of Patent eGrant | 05 Sep, 2023 | US11746141 |
| Recordation of Patent Grant Mailed Critical | 05 Sep, 2023 | US11746141 |
| Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
| Mail Patent eGrant Notification | 05 Sep, 2023 | US11746141 |
| Email Notification Critical | 05 Sep, 2023 | US11746141 |
| Email Notification Critical | 18 Aug, 2023 | US11746141 |
| Issue Notification Mailed Critical | 16 Aug, 2023 | US11746141 |
| Dispatch to FDC | 20 Jul, 2023 | US11746141 |
| Application Is Considered Ready for Issue Critical | 20 Jul, 2023 | US11746141 |
Bupivacaine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Bupivacaine Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Bupivacaine Hydrochloride. The first generic version for Bupivacaine Hydrochloride was by Hospira Inc and was approved on Feb 17, 1986. And the latest generic version is by Aspiro Pharma Ltd and was approved on Mar 27, 2024.
Given below is the list of companies who have filed for Bupivacaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ASPIRO
Aspiro Pharma Ltd has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | Mar 27, 2024 |
| 0.5% | injectable | Prescription | INJECTION | AP | Mar 27, 2024 |
| 0.75% | injectable | Prescription | INJECTION | AP | Mar 27, 2024 |
Manufacturing Plant Locations New
Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. B BRAUN MEDICAL INC
B Braun Medical Inc has filed for 1 generic for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by B Braun Medical Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75% | injectable | Prescription | SPINAL | AP | Apr 2, 2019 |
Manufacturing Plant Locations New
B Braun Medical Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of B Braun Medical Inc as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. BAXTER HLTHCARE CORP
Baxter Healthcare Corp has filed for 1 generic for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75% | injectable | Discontinued | SPINAL | N/A | Jul 25, 2016 |
4. CIVICA
Civica Inc has filed for 1 generic for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Civica.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5% | injectable | Discontinued | INJECTION | N/A | Feb 19, 2019 |
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. Out of these 0.75% version comes by the name BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | May 13, 2016 |
| 0.5% | injectable | Prescription | INJECTION | AP | May 13, 2016 |
| 0.75% | injectable | Prescription | INJECTION | AP | Nov 5, 2013 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
6. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. All of these versions come by the name SENSORCAINE. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | May 21, 1986 |
| 0.75% | injectable | Discontinued | SPINAL | N/A | Apr 15, 1987 |
| 0.5% | injectable | Prescription | INJECTION | AP | May 21, 1986 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
7. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. All of these versions come by the name BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | Feb 11, 2021 |
| 0.5% | injectable | Prescription | INJECTION | AP | Feb 11, 2021 |
| 0.75% | injectable | Prescription | INJECTION | AP | Feb 11, 2021 |
8. HOSPIRA
Hospira Inc has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5% | injectable | Prescription | INJECTION | AP | Mar 3, 1987 |
| 0.25% | injectable | Discontinued | INJECTION | N/A | Mar 3, 1987 |
| 0.75% | injectable | Prescription | SPINAL | AP | Dec 11, 1987 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
9. HUONS
Huons Co Ltd has filed for 1 generic for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Huons.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75% | injectable | Prescription | SPINAL | AP | Dec 30, 2019 |
Manufacturing Plant Locations New
Huons's manufacturing plants are situated in 1 country - Korea (the Republic of). Given below are the details of these plant locations as well as the firm names of Huons as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Korea (the Republic of) |
| |||
10. INTL MEDICATED
International Medicated Systems Ltd has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. All of these versions come by the name BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Intl Medicated.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.75% | injectable | Discontinued | INJECTION | N/A | Jan 9, 2002 |
| 0.25% | injectable | Discontinued | INJECTION | N/A | Jan 9, 2002 |
| 0.5% | injectable | Discontinued | INJECTION | N/A | Jan 9, 2002 |
11. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | Dec 27, 2023 |
| 0.5% | injectable | Prescription | INJECTION | AP | Dec 27, 2023 |
| 0.75% | injectable | Prescription | INJECTION | AP | Dec 27, 2023 |
12. SOMERSET
Somerset Therapeutics Llc has filed for 2 different strengths of generic version for Bupivacaine Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | injectable | Prescription | INJECTION | AP | Nov 20, 2023 |
| 0.5% | injectable | Prescription | INJECTION | AP | Nov 20, 2023 |
Manufacturing Plant Locations New
Somerset's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Somerset as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
13. STERISCIENCE SPECLTS
Steriscience Specialities Pte Ltd has filed for 3 different strengths of generic version for Bupivacaine Hydrochloride. Out of these 0.75% version comes by the name BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Steriscience Speclts.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.5% | injectable | Prescription | INJECTION | AP | Oct 18, 2011 |
| 0.25% | injectable | Prescription | INJECTION | AP | Oct 18, 2011 |
| 0.75% | injectable | Prescription | INJECTION | AP | Oct 18, 2011 |